Calcium Gluconate 10%
Brand names: Calcium Gluconate 10% Injection
Calcium gluconate 10% is an intravenous calcium salt used in emergencies for cardiac membrane protection in severe hyperkalaemia, symptomatic hypocalcaemia, and as an antidote in magnesium or calcium-channel-blocker toxicity and hydrofluoric acid burns.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Calcium ions antagonise the membrane effects of hyperkalaemia by restoring the resting potential and stabilise myocardial and neuromuscular excitability.
Prescribing in practice
- It provides less elemental calcium per volume than calcium chloride, so the salts are not interchangeable and the correct salt and strength must be confirmed for the indication.
- It is less irritant than calcium chloride and so is often preferred for peripheral administration, but extravasation can still cause tissue injury and it should be given slowly with cardiac monitoring.
- Avoid co-administration with bicarbonate- or phosphate-containing fluids, which precipitate, and use caution in patients taking digoxin.
Monitoring
Monitor ECG continuously alongside serum calcium and potassium, and watch the cannula site during administration.
Counselling the patient
- Keep calcium-containing and bicarbonate/phosphate infusions in separate lines.
- In hyperkalaemia calcium only buys time; potassium-lowering measures must follow.
- Distinguish clearly between calcium gluconate and calcium chloride preparations.
Evidence & guidelines
Calcium gluconate for cardioprotection in hyperkalaemia is recommended in UK renal association and Resuscitation Council UK hyperkalaemia guidance.
Reference: UK Renal Association Hyperkalaemia Guidelines 2020; NICE; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- AmlodipineRecommendedDihydropyridine Calcium Channel Blocker
- VerapamilRecommendedNon-Dihydropyridine Calcium Channel Blocker
- DiltiazemRecommendedNon-Dihydropyridine Calcium Channel Blocker
Featured in these MRCEM clinical pathways
Calcium Gluconate 10% is a core drug in the following exam-focused workups on our sister siteReviseMRCEM.
MRCEM Primary / Intermediate / OSCE candidates: each pathway includes exam-style questions, RCEM/NICE citations, and FAQ summaries.